KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares Issued
Ratios

Jazz Pharmaceuticals (JAZZ) Short-Term Debt issuances: 2009-2011

Historic Short-Term Debt issuances for Jazz Pharmaceuticals (JAZZ) over the last 1 years, with Sep 2011 value amounting to -$4.0 million.

  • Jazz Pharmaceuticals' Short-Term Debt issuances fell 154.42% to -$4.0 million in Q3 2011 from the same period last year, while for Sep 2011 it was $14.7 million, marking a year-over-year decrease of 34.78%. This contributed to the annual value of $500.0 million for FY2020, which is N/A change from last year.
  • Per Jazz Pharmaceuticals' latest filing, its Short-Term Debt issuances stood at -$4.0 million for Q3 2011, which was down 200.00% from $4.0 million recorded in Q1 2011.
  • Jazz Pharmaceuticals' Short-Term Debt issuances' 5-year high stood at $9.4 million during Q4 2009, with a 5-year trough of -$4.0 million in Q3 2011.
  • In the last 3 years, Jazz Pharmaceuticals' Short-Term Debt issuances had a median value of $5.7 million in 2010 and averaged $4.1 million.
  • Over the last 5 years, Jazz Pharmaceuticals' Short-Term Debt issuances had its largest YoY gain of 356.57% in 2011, and its largest YoY loss of 154.42% in 2011.
  • Over the past 3 years, Jazz Pharmaceuticals' Short-Term Debt issuances (Quarterly) stood at $9.4 million in 2009, then dropped by 21.80% to $7.3 million in 2010, then tumbled by 154.42% to -$4.0 million in 2011.
  • Its Short-Term Debt issuances was -$4.0 million in Q3 2011, compared to $4.0 million in Q1 2011 and $7.3 million in Q4 2010.